Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: FENC) | Delayed: 10.70 +0.16 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.54 | 52 Week High | $ | |||
| Open | $10.63 | 52 Week Low | $ | |||
| Day High | $10.83 | P/E | N/A | |||
| Day Low | $10.22 | EPS | $ | |||
| Volume | 135,036 | |||||
